Astera Labs (NASDAQ:ALAB) Shares Down 8.2% – Here’s Why

Shares of Astera Labs, Inc. (NASDAQ:ALAB) fell 8.2% during trading on Wednesday . The stock traded as low as $331.28 and last traded at $331.87. 2,354,870 shares traded hands during trading, a decline of 57% from the average session volume of 5,537,341 shares. The stock had previously closed at $361.67.

Wall Street Analysts Forecast Growth

ALAB has been the topic of a number of research reports. UBS Group restated a “neutral” rating and issued a $425.00 price objective on shares of Astera Labs in a report on Wednesday. Royal Bank Of Canada boosted their price objective on shares of Astera Labs from $425.00 to $500.00 and gave the stock an “outperform” rating in a research note on Wednesday. JPMorgan Chase & Co. raised their target price on shares of Astera Labs from $205.00 to $280.00 and gave the company an “overweight” rating in a research note on Wednesday, May 6th. TD Cowen lowered their price target on Astera Labs from $425.00 to $375.00 and set a “hold” rating for the company in a report on Wednesday. Finally, Stifel Nicolaus boosted their price objective on Astera Labs from $260.00 to $460.00 and gave the stock a “buy” rating in a research note on Wednesday, June 24th. Thirteen research analysts have rated the stock with a Buy rating and ten have assigned a Hold rating to the stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $325.25.

Astera Labs Stock Performance

The company has a market capitalization of $56.65 billion, a PE ratio of 163.61, a P/E/G ratio of 3.69 and a beta of 3.84. The firm has a fifty day simple moving average of $360.62 and a 200-day simple moving average of $234.58.

Astera Labs (NASDAQ:ALAB) last posted its quarterly earnings results on Tuesday, August 4th. The company reported $0.80 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.69 by $0.11. The firm had revenue of $392.40 million for the quarter, compared to analysts’ expectations of $360.85 million. Astera Labs had a net margin of 30.74% and a return on equity of 20.46%. The firm’s quarterly revenue was up 104.5% on a year-over-year basis. During the same period in the prior year, the company posted $0.44 earnings per share. Astera Labs has set its Q3 2026 guidance at 1.160-1.210 EPS. As a group, research analysts anticipate that Astera Labs, Inc. will post 1.86 EPS for the current fiscal year.

Insiders Place Their Bets

In related news, General Counsel Philip Mazzara sold 14,076 shares of the business’s stock in a transaction dated Monday, May 18th. The stock was sold at an average price of $231.78, for a total value of $3,262,535.28. Following the completion of the sale, the general counsel directly owned 104,139 shares of the company’s stock, valued at $24,137,337.42. The trade was a 11.91% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, COO Sanjay Gajendra sold 400,000 shares of the company’s stock in a transaction that occurred on Thursday, May 21st. The shares were sold at an average price of $290.30, for a total value of $116,120,000.00. Following the sale, the chief operating officer owned 5,064,213 shares in the company, valued at $1,470,141,033.90. The trade was a 7.32% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last ninety days, insiders sold 1,244,395 shares of company stock valued at $358,865,571. 10.40% of the stock is owned by company insiders.

Hedge Funds Weigh In On Astera Labs

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in ALAB. Royal Bank of Canada lifted its holdings in Astera Labs by 167.3% in the 1st quarter. Royal Bank of Canada now owns 152,453 shares of the company’s stock worth $9,097,000 after purchasing an additional 95,409 shares during the last quarter. AQR Capital Management LLC grew its holdings in shares of Astera Labs by 213.4% during the 1st quarter. AQR Capital Management LLC now owns 11,391 shares of the company’s stock worth $680,000 after purchasing an additional 7,756 shares in the last quarter. Empowered Funds LLC increased its holdings in Astera Labs by 917.3% in the 1st quarter. Empowered Funds LLC now owns 4,639 shares of the company’s stock valued at $277,000 after buying an additional 4,183 shares during the period. First Trust Advisors LP raised its position in Astera Labs by 102.0% in the second quarter. First Trust Advisors LP now owns 112,766 shares of the company’s stock worth $10,196,000 after purchasing an additional 56,952 shares in the last quarter. Finally, Brown Advisory Inc. lifted its position in shares of Astera Labs by 54.9% during the 2nd quarter. Brown Advisory Inc. now owns 5,581 shares of the company’s stock worth $505,000 after buying an additional 1,977 shares during the period. Institutional investors and hedge funds own 60.47% of the company’s stock.

Astera Labs Company Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.